Search Results - "Granström, Ola"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review by Higashi, Kyoko, Medic, Goran, Littlewood, Kavi J., Diez, Teresa, Granström, Ola, De Hert, Marc

    Published in Therapeutic advances in psychopharmacology (01-08-2013)
    “…Background: Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment. Methods: We performed a systematic review…”
    Get full text
    Journal Article
  2. 2

    The societal cost of bipolar disorder in Sweden by Ekman, Mattias, Granström, Ola, Omérov, Sead, Jacob, Johanna, Landén, Mikael

    “…Purpose There is a lack of comprehensive cost-of-illness studies in bipolar disorder, in particular studies based on patient-level data. The purpose of this…”
    Get full text
    Journal Article
  3. 3

    Cost-effectiveness of dapagliflozin (Forxiga® ) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries by Sabale, Ugne, Ekman, Mattias, Granström, Ola, Bergenheim, Klas, McEwan, Phil

    Published in Primary care diabetes (01-02-2015)
    “…Highlights • Dapagliflozin – a sodium-glucose co-transporter 2 inhibitor working independently of insulin. • Long term diabetes-related complications are…”
    Get full text
    Journal Article
  4. 4

    Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis by Medic, Goran, Higashi, Kyoko, Littlewood, Kavi J, Diez, Teresa, Granström, Ola, Kahn, René S

    Published in Neuropsychiatric disease and treatment (01-01-2013)
    “…The purpose of this study was to investigate the impact of dosing frequency on adherence in severe chronic psychiatric and neurological diseases. A systematic…”
    Get full text
    Journal Article
  5. 5

    Cost-effectiveness of saxagliptin (Onglyza® ) in type 2 diabetes in Sweden by Granström, Ola, Bergenheim, Klas, McEwan, Phil, Sennfält, Karin, Henriksson, Martin

    Published in Primary care diabetes (01-07-2012)
    “…Abstract Aim The objective of this study was to investigate the cost-effectiveness of saxagliptin (Onglyza® ), a DPP-4 inhibitor, plus metformin compared with…”
    Get full text
    Journal Article
  6. 6

    The societal cost of schizophrenia in Sweden by Ekman, Mattias, Granstrom, Ola, Omerov, Sead, Jacob, Johanna, Landen, Mikael

    “…Schizophrenia is a disabling psychiatric disorder that has severe consequences for patients and their families. Moreover, the expensive treatment of…”
    Get more information
    Journal Article
  7. 7

    Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders by Hallinen, Taru, Soini, Erkki J, Granström, Ola, Ovaskainen, Yrjö, Leinonen, Esa, Koponen, Hannu J, Hänninen, Kari

    Published in BMJ open (01-01-2012)
    “…ObjectiveExtended release (XR) and immediate release (IR) quetiapine have differing dosing, titration and plasma concentration profiles. The authors assessed…”
    Get full text
    Journal Article
  8. 8

    Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension by Granström, Ola, Levin, Lars-Åke, Henriksson, Martin

    Published in ClinicoEconomics and outcomes research (01-01-2012)
    “…Although angiotensin receptor blockers have different receptor binding properties, no comparative randomized studies with cardiovascular event endpoints have…”
    Get full text
    Journal Article
  9. 9